Gardasil 9 syringe 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FRDCV
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,980
Award facts
- Contract value 100% obligated
- $13,979.68 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $13,979.68 by the Defense Logistics Agency (DLA) for the supply of Gardasil 9 Syringe 0.5ML, a human papillomavirus vaccine. The contract, awarded on September 2, 2025, with an ultimate completion date of September 3, 2025, operates under a firm fixed-price structure with no set-aside designation. This delivery order is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through December 2026 that enables the company to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide.
The placement of performance in Conshohocken, Pennsylvania reflects AmerisourceBergen's operational headquarters and its role as a critical vendor within the federal medical procurement system. This award demonstrates the company's continued utilization of its prime IDC vehicle to fulfill DLA's vaccination supply requirements for military and related healthcare systems. The competitively awarded delivery order aligns with DLA Troop Support's broader pharmaceutical procurement strategy and AmerisourceBergen's extensive portfolio of medical product deliveries, which encompasses vaccines, specialty medications, and other essential healthcare commodities across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FRDCV?
SPE2DB25FRDCV was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 2, 2025.
How much is contract SPE2DB25FRDCV worth?
The government has obligated $13,980 on SPE2DB25FRDCV.
Is contract SPE2DB25FRDCV an order under another contract?
Yes. SPE2DB25FRDCV is a delivery order under SPE2DB25D3008, an indefinite delivery contract.
Was contract SPE2DB25FRDCV competed?
The extent of competition for SPE2DB25FRDCV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award